ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 34040697

Liquid biopsy in cholangiocarcinoma: Current status and future perspectives.

Rompianesi G and 4 others. World J Gastrointest Oncol, 2021. Cited by 45 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Liquid biopsy in cholangiocarcinoma: Current status and future perspectives. Papers, record 34040697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34040697

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Liquid biopsy in cholangiocarcinoma: Current status and future perspectives.
PubMed
Journal
World J Gastrointest Oncol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
2.76
iCite
Revised in PubMed
2021-05-28
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rompianesi GGianluca
2Di Martino MMarcello
3Gordon-Weeks AAlex
4Montalti RRoberto
5Troisi RRoberto

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References203

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,317,891Circulating tumor cells, disease progression, and survival in metastatic breast cancer.N Engl J Med2004https://conductscience.org/library/papers/15317891PubMed
233,161,598The association between circulating MicroRNA-150 level and cholangiocarcinoma.J Clin Lab Anal2020https://conductscience.org/library/papers/33161598PubMed
316,858,537Role of epigenetic alterations in cholangiocarcinoma.J Hepatobiliary Pancreat Surg2006https://conductscience.org/library/papers/16858537PubMed
424,166,007Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer.Int J Cancer2014https://conductscience.org/library/papers/24166007PubMed
524,581,682Cholangiocarcinoma.Lancet2014https://conductscience.org/library/papers/24581682PubMed
630,325,540Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.Hepatology2019https://conductscience.org/library/papers/30325540PubMed
727,095,655Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Nat Rev Gastroenterol Hepatol2016https://conductscience.org/library/papers/27095655PubMed
826,501,712Systematic Review and Meta-analysis of Current Experience in Treating IPNB: Clinical and Pathological Correlates.Ann Surg2016https://conductscience.org/library/papers/26501712PubMed
930,797,05118F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis.J Hepatol2019https://conductscience.org/library/papers/30797051PubMed
1010,769,604Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: a clinician's perspective.Trop Gastroenterol1999https://conductscience.org/library/papers/10769604PubMed

1 to 10 of 203

See all 203 references

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
42,964,795Same organ, divergent immunity: T-cell exhaustion versus stromal exclusion in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.Front Immunol2026https://conductscience.org/library/papers/42964795PubMed
42,910,203Asia-Pacific Transplant Oncology Symposium 2024: Expert Statements on the Current State and Future Direction of Hepatobiliary Surgical and Transplant Oncology.Liver Cancer2026https://conductscience.org/library/papers/42910203PubMed
42,183,187Present and future of liver transplantation for cholangiocellular carcinoma: moving toward personalized multiparametric transplantability patterns.Transpl Int2026https://conductscience.org/library/papers/42183187PubMed
42,123,365Advances in In Vitro Diagnostics for Cholangiocarcinoma: From Biomarker Discovery to Artificial Intelligence.Int J Mol Sci2026https://conductscience.org/library/papers/42123365PubMed
41,939,857Exosomes and cholangiocarcinoma: mechanisms, diagnostic, and therapeutic perspectives.Front Immunol2026https://conductscience.org/library/papers/41939857PubMed
41,399,682Bile cell-free DNA shows benefit as a potential sample for somatic mutation detection of resectable cholangiocarcinoma.ILIVER2025https://conductscience.org/library/papers/41399682PubMed
41,095,804Point-of-Care Testing and Biomarkers in Biliary Diseases: Current Evidence and Future Directions.J Clin Med2025https://conductscience.org/library/papers/41095804PubMed
40,647,454Advancing Cholangiocarcinoma Diagnosis: The Role of Liquid Biopsy and CRISPR/Cas Systems in Biomarker Detection.Cancers (Basel)2025https://conductscience.org/library/papers/40647454PubMed
40,631,805The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review.BJS Open2025https://conductscience.org/library/papers/40631805PubMed
40,585,845Biliary tract cancers: advances in diagnostic and management.Explor Target Antitumor Ther2025https://conductscience.org/library/papers/40585845PubMed

1 to 10 of 35

See all 35 cited by

Genes58

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ARID1A8,289PubTator's text mininghttps://conductscience.org/library/genes/8289NCBI Gene
BAP18,314PubTator's text mininghttps://conductscience.org/library/genes/8314NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
CDKN2A1,029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
CXCL83,576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
ELF31,999PubTator's text mininghttps://conductscience.org/library/genes/1999NCBI Gene
EPCAM4,072PubTator's text mininghttps://conductscience.org/library/genes/4072NCBI Gene
ERBB22,064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERBB32,065PubTator's text mininghttps://conductscience.org/library/genes/2065NCBI Gene

1 to 10 of 58

See all 58 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34040697

GET https://conductscience.org/api/papers/v1/34040697/references?page=2

API referenceFor AI assistants